HP Site Belle Isle
- Address
- 20 Rue Belle Isle, 57045 Metz, France
HP Site Belle Isle - Vasculitis Research Center
HP Site Belle Isle specializes in advanced clinical research focused on systemic autoimmune diseases, with particular expertise in ANCA-associated vasculitis. The center participates in multicenter trials investigating optimal treatment strategies for maintaining disease remission in patients with complex vasculitic conditions.
- Granulomatosis with polyangiitis (GPA, Wegener's) remission maintenance
- Microscopic polyangiitis (MPA) treatment optimization
- ANCA-associated vasculitis immunosuppressive therapy protocols
- Corticosteroid tapering strategies in autoimmune vasculitis
The center conducts rigorous prospective comparative studies evaluating extended prednisone administration regimens in combination with rituximab therapy to optimize remission maintenance while minimizing long-term corticosteroid exposure. Research protocols utilize validated assessment tools including the Birmingham Vasculitis Activity Score (BVAS) to ensure comprehensive monitoring of disease activity and treatment response over extended follow-up periods.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Hospices Civils De Lyon1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HP Site Belle Isle
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Remission Maintenance with Extended Prednisone Administration in ANCA-Associated Vasculitis Using Rituximab Therapy | Hospices Civils De Lyon | Phase III | Recruiting | Aug 2019 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Microcrystalline Cellulose | 1 | Unknown | 2019-08-20 | 2019-08-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.